Lypo
En vente sur le marché américain (selon le DSLD)
TransFormation Professional Protocol, food supplement from the US market
Lypo (TransFormation Professional Protocol), a food supplement au code-barres 632889400611, is described by its US market label, recorded on 18 July 2023. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 18 July 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- TransFormation Professional Protocol
- Barcode
- 632889400611
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Hypromellose, Water
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin E | Vitamin | 1.7 mg |
| Chromium | Mineral | 100 µg |
| Lipase | Enzyme | 21 mg |
| Garcinia cambogia Fruit Extract (Garcinia mangostana) | Plant | 150 mg |
| Tzyme Polysaccharolytic Blend | Blend | 36 mg |
| Amylase | Enzyme | not stated |
| Alpha-Galactosidase | Enzyme | not stated |
| Lactase | Enzyme | not stated |
| Diastase | Enzyme | not stated |
| Invertase | Enzyme | not stated |
| Glucoamylase | Enzyme | not stated |
| Gugulipid (Commiphora mukul) | Plant | 60 mg |
| Bladderwrack Algae | Other | 60 mg |
| Tzyme AntiOx Blend | Blend | 49 mg |
| Dunaliella extract | Other | not stated |
| Alpha-Lipoic Acid | Other substance | not stated |
| Eleuthero (Eleutherococcus senticosus) | Plant | not stated |
| Asian Ginseng (Panax ginseng) | Plant | not stated |
| Coenzyme Q-10 | Other substance | not stated |
| Flaxseed (Linum usitatissimum) | Plant | not stated |
| Garlic (Allium sativum) | Plant | 40 mg |
| Lecithin | Fat | 40 mg |
| Tzyme Protease Blend | Blend | 103 mg |
| Peptidase | Enzyme | not stated |
| Bromelain | Enzyme | not stated |
| Artichoke Leaf Extract | Plant | 30 mg |
| Rice Bran | Fibre | 51 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging